Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (1627)	3/16/1999 11:47:00 AM
From: John F Beule	Read Replies (2) \| Respond to of 2539

GeneTrace Systems Inc. Announces Addition to Board of Directors ALAMEDA, Calif., March 16 /PRNewswire/ -- GeneTrace Systems Inc., a privately held genomics, proteomics and bioinformatics company, today announced the appointment of Mr. James B. Glavin to the company's Board of Directors. Mr. Glavin is chairman of The Immune Response Corporation (IMNR) where he served as President & CEO from 1987 to 1994. Mr. Glavin has over 30 years of management, finance and marketing experience in the healthcare and biotechnology industries. Prior to joining The Immune Response Corporation, he served as president and CEO of Genetics Systems Corporation from 1980 to 1983, and chairman of the board from 1983 to 1985. He served as vice president of sales and marketing at Oximetrics from 1979 to 1980, and previously held various sales and marketing positions with Baxter Laboratories. In the area of finance, he has been a partner at C.H. Ventures and a healthcare analyst for Montgomery Securities. He has a degree in economics and an MBA from the Harvard Business School. "Jim Glavin brings a wealth of experience to the company at a critical juncture in GeneTrace's development," said Dr. George B. LaMotte III, chief executive officer of GeneTrace Systems Inc. "His broad background in healthcare will be extremely useful as we introduce our first products for the pharmaceutical side of our business." Mr. Glavin joins a board of directors that also includes Richard J. Stonard, Ph.D. and Alan Herzig. Dr. Stonard joined the company's board of directors in 1998. He has 17 years of experience at Monsanto Company in genomics research and the commercialization of novel biotechnology products. He is currently Head of the Genomics Network of Monsanto and Chairman of the Monsanto Genomics Council. He also serves on the board of directors of N. T. Gargiulo, Inc. and the oversight board of Cereon Genomics, LLC. Dr. Stonard holds a B.Sc. (Hons.) in biochemistry from McMaster University and a Ph.D. in chemistry from the University of British Columbia. Alan Herzig has served on the company's board of directors since 1998. His business career includes 15 years as a corporate executive (primarily in the computer services industry), 15 years as a senior investment banker and 7 years as a venture capitalist. He currently advises SRI International and its subsidiary, Sarnoff Corporation, on the commercialization of their technologies and serves on the boards of several of their spin-off companies. Most recently he served as president and chief executive officer of Robert Fleming Pacific, Inc., the U.S. investment banking arm of Robert Fleming & Co., a leading merchant bank based in the United Kingdom. He has also served as managing director of L. F. Rothschild Unterberg Towbin, where he was responsible for their West Coast corporate finance department. Based in Alameda, California, GeneTrace Systems Inc. is a privately held company integrating genomic and proteomic tools with bioinformatic systems to accelerate the discovery and development of novel therapeutic targets and drugs, and agricultural products. The company's core technology platforms include: genotyping through the characterization of single nucleotide polymorphisms (SNPs) and microsatellites; high-throughput gene expression screening of chemical compound-treated cells; the analysis of gene expression patterns for target discovery; and systems for proteomics analysis. GeneTrace has entered into an exclusive alliance with Monsanto Company for agricultural applications of its technology; the two companies have an ongoing collaboration initially focused on genotyping selected plants and animals. GeneTrace is actively seeking drug and target discovery collaborations with pharmaceutical, biotechnology and genomics companies. SOURCE GeneTrace Systems Inc. CO: GeneTrace Systems Inc. ST: California IN: MTC SU: PER 03/16/99 11:00 EST prnewswire.com To edit your profile, go to keyword NewsProfiles. For all of today's news, go to keyword News.

To: Anthony Wong who wrote (1627)	3/16/1999 2:23:00 PM
From: Dan Spillane	Read Replies (1) \| Respond to of 2539

TEXT-Greenspan's farm economy speech (highlights) 3/16/1999 "Over time, farms thereby become fewer in number but are larger and, in most cases, more efficient, with strengthened ties to nonfarm businesses that supply inputs that are essential to improved technologies. The new technologies seem destined to integrate farming operations still more tightly into our complex modern economy." "I cannot stress too much the overwhelming importance of technical change as a primary force that will likely be reshaping farm supply conditions--as it has been doing for a long time. As a consequence of each producer's striving to become more efficient and thereby to contain costs, successive waves of innovation have swept through the farm sector over the decades. Crop producers, in stages, have implemented increased mechanization, heavier uses of fertilizers, new higher-yielding varieties of seeds, low-tillage methods of production that have enabled producers to economize on energy inputs, and heavier reliance on chemicals and pesticides to reduce crop losses. The payoff to these efforts is evident in gains in national average yields per acre of roughly 40 percent to 60 percent for our major field crops--corn, wheat, soybeans, and cotton--over the past three decades." "Moreover, some promising applications of new technologies are more farm specific. Combinations of electronic sensors, computers, and communications equipment are starting to give producers more control over farming operations that have always been vulnerable to pests or subject to the whims of nature. Applications of biotechnology have taken hold already in some parts of farming, and numerous new possibilities seem to be opening up." (full text) biz.yahoo.com